Enveric Biosciences Inc Capital Reinvestment Ratio

Latest as of June 2018: 0.08x

Enveric Biosciences Inc capital reinvestment ratio. Enveric Biosciences Inc (ENVB) has a Capital Reinvestment Ratio of 0.08x as of June 2018, meaning it reinvests 0% of its operating cash flow ($180.21K) in capital expenditures ($13.88K). See ENVB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$180.21K
USD

Capital Expenditures

$13.88K
USD

Data as of

Jun 2018
Most recent filing

Capital Reinvestment Ratio of Enveric Biosciences Inc (2000–2004)

Capital reinvestment ratio of Enveric Biosciences Inc from 2000 to 2004. This chart tracks Enveric Biosciences Inc's Capital Reinvestment Ratio across 3 annual periods. See financial agility of Enveric Biosciences Inc to measure the company's free cash flow as a share of total liabilities.

Enveric Biosciences Inc Capital Reinvestment Ratio by Year (2000–2004)

Enveric Biosciences Inc capital reinvestment ratio by year from 2000 to 2004. For the full cash flow conversion analysis, see Enveric Biosciences Inc cash conversion from operations.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2004 0.01x $343.94K $4.01K ▼ -98.7%
2002 0.88x $85.14K $74.99K ▲ +217.3%
2000 0.28x $145.84K $40.49K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow